483 related articles for article (PubMed ID: 17619861)
1. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA
Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861
[TBL] [Abstract][Full Text] [Related]
2. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
Perreault ML; Graham D; Bisnaire L; Simms J; Hayton S; Szechtman H
Neuropsychopharmacology; 2006 Sep; 31(9):1967-81. PubMed ID: 16237381
[TBL] [Abstract][Full Text] [Related]
3. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
Escobar AP; González MP; Meza RC; Noches V; Henny P; Gysling K; España RA; Fuentealba JA; Andrés ME
Int J Neuropsychopharmacol; 2017 Aug; 20(8):660-669. PubMed ID: 28531297
[TBL] [Abstract][Full Text] [Related]
5. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Perreault ML; Seeman P; Szechtman H
Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
[TBL] [Abstract][Full Text] [Related]
6. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
Beerepoot P; Lam V; Luu A; Tsoi B; Siebert D; Szechtman H
Neurosci Lett; 2008 Dec; 446(2-3):101-4. PubMed ID: 18824069
[TBL] [Abstract][Full Text] [Related]
7. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
[TBL] [Abstract][Full Text] [Related]
8. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
Heidbreder CA; Schenk S; Partridge B; Shippenberg TS
Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
[TBL] [Abstract][Full Text] [Related]
9. D2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation.
Szumlinski KK; Szechtman H
Neuroreport; 2002 Apr; 13(5):563-6. PubMed ID: 11973446
[TBL] [Abstract][Full Text] [Related]
10. Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex.
Szumlinski KK; Goodwill AM; Szechtman H
Psychopharmacology (Berl); 2000 Oct; 152(3):304-11. PubMed ID: 11105941
[TBL] [Abstract][Full Text] [Related]
11. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
[TBL] [Abstract][Full Text] [Related]
12. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.
Izenwasser S; Acri JB; Kunko PM; Shippenberg T
Synapse; 1998 Nov; 30(3):275-83. PubMed ID: 9776131
[TBL] [Abstract][Full Text] [Related]
13. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
Johnson EF; Szechtman H
Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
[TBL] [Abstract][Full Text] [Related]
14. Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K+ induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats.
Escobar Adel P; Cornejo FA; Andrés ME; Fuentealba JA
Neurochem Int; 2012 Mar; 60(4):344-9. PubMed ID: 22306346
[TBL] [Abstract][Full Text] [Related]
15. Kappa opioid mediated locomotor activity in the preweanling rat: role of pre- and postsynaptic dopamine receptors.
McDougall SA; Garmsen GM; Meier TL; Crawford CA
Psychopharmacology (Berl); 1997 Sep; 133(1):62-8. PubMed ID: 9335082
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric modulation of a catecholamine-regulated protein in the rat brain, following quinpirole administration.
Gabriele J; Culver K; Sharma S; Zhang B; Szechtman H; Mishra R
Synapse; 2003 Sep; 49(4):261-9. PubMed ID: 12827645
[TBL] [Abstract][Full Text] [Related]
17. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
Culver KE; Szechtman H; Levant B
Eur J Pharmacol; 2008 Sep; 592(1-3):67-72. PubMed ID: 18644362
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.
Ridray S; Griffon N; Mignon V; Souil E; Carboni S; Diaz J; Schwartz JC; Sokoloff P
Eur J Neurosci; 1998 May; 10(5):1676-86. PubMed ID: 9751140
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine-induced preprodynorphin mRNA expression and kappa-opioid receptor binding in basal ganglia of adult rats after prenatal exposure to diazepam.
Inderbitzin S; Lauber ME; Schlumpf M; Lichtensteiger W
Brain Res Dev Brain Res; 1997 Jan; 98(1):114-24. PubMed ID: 9027410
[TBL] [Abstract][Full Text] [Related]
20. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
Culver KE; Szechtman H
Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
